SARS-CoV-2 diagnostic pipeline
FIND is collating an overview of SARS-CoV-2 tests that are commercially available or in development for the diagnosis of COVID-19. We do not guarantee that this is a comprehensive list, since the information below has been submitted voluntarily by test suppliers and is not independently verified. If you have any queries or wish for us to make updates in the pipeline, please contact us.
If you would like your test to be included in the pipeline, please click on this button to download the form. Submission form
To know more about the FIND evaluations of submitted SARS-CoV-2 tests, click here. ongoing test evaluations
EUA: Emergency Use Authorization — HSA: Health & Safety/Sciences Authority — MFDS: Ministry of Food & Drug Safety — MoH: Ministry of Health — MHRA: Medicines & Health Care Products Regulatory Agency — NRA: National Regulatory Authority — RUO: Research Use Only — TGA: Therapeutic Goods Administration — WHO EUL: World Health Organization Emergency Use Listing
- Beijing Infervision Technology Co. Ltd InferRead CT Pneumonia (In development)
- Canary Health Technologies AiroStotleCV19 (Breath VOCs) (In development)
- Finbiosoft Results Manager (automatic PCR interpretation software) (RUO)
- Intrasense SA Myrian Covid-19 (China NMPA EUA - US FDA EUA - CE-IVD)
- Jetware SRL LOMT - Pool Testing Management Software (In development)
- L7 Informatics Enterprise Science Platform (CLIA)
- Visible Patient Visible Patient Service - numerical (medical image analysis, CT or MRI) (US FDA 501(k) - CE Class IIa)